GI side effects usually stabilize during this phase
while G6PD status is not measured by a standard CBC, abnormal RBC morphology can surface when hemolysis is active and is worth tracking in context
Combined with the above research results, we can use these substances regulating oxidative stress as potential therapeutic drugs for KOA and verify the ability of these substances to regulate ROS in the pathogenesis of KOA in animal experiments
Common maintenance approaches include staying at the dose where you stabilized (often 1.0 to 1.7 mg), reducing by one dose level from your peak (e.g., from 2.4 mg to 1.7 mg), or finding the minimum dose that prevents weight regain while minimizing side effects
Antibiotic use, probiotic supplementation, and dietary patterns all influence gut microbiome composition and therefore TMAO production
Another advantage is their custom dosing protocols